PTPI — Petros Pharmaceuticals, Inc.
—
OTC ·
Health Care ·
Pharmaceuticals ·
CIK 1815903 ·
Last close
$0.00
Market Cap
$139.8K
52W High
$0.02
52W Low
$0.00
ADV30
132,522
Next earnings
—
Quarterly Fundamentals
Revenues vs Net Income (last 4 Q)
Assets vs Liabilities (last 4 Q)
| Period | Revenues | Gross profit | Op income | Net income | Assets | Cash | Liabilities |
|---|---|---|---|---|---|---|---|
| Jun 2026 | 0 | — | -988,501 | -955,625 | 3,545,719 | 3,488,595 | 2,844,825 |
| Mar 2026 | 0 | — | -1,027,179 | -987,036 | 4,394,450 | 4,352,450 | 2,623,135 |
| Dec 2025 | 0 | — | -391,486 | -336,506 | 5,163,598 | 5,136,722 | 2,292,744 |
| Sep 2025 | 0 | — | -990,737 | -922,723 | 6,133,468 | 6,070,266 | 2,765,381 |
Cashflow TTM (yfinance, fills SEC gap)
Operating CF
$-3,715,595
Investing CF
$0
Financing CF
$-117,311
CapEx
—
Dividends Paid
—
Buybacks
$-341,560
EPS Diluted TTM
$-1.56
As of
2026-11-15
Balance + Analyst (yfinance extras)
Retained Earnings
$-113,237,437
Inventory
$1,302,484
Receivables
$443,555
ST Investments
—
EBIT TTM
$-3,397,903
Pretax Income TTM
$-3,201,890
Interest Exp TTM
—
Analysts
—
Annual Trend (SEC EDGAR, last 5y)
Revenues vs Net Income (last 5y)
| FY end | Revenues | Op income | Net income | Assets | Liabilities | Equity | Op cash flow |
|---|---|---|---|---|---|---|---|
| Dec 2025 | 0 | -4,641,350 | 1,913,595 | 5,160,000 | 2,292,744 | 2,870,854 | -6,734,707 |
| Dec 2024 | 0 | -4,626,943 | -14,318,790 | 10,635,310 | 18,102,888 | -7,467,578 | -2,603,051 |
| Dec 2023 | 5,822,388 | -10,762,364 | -8,163,188 | 33,800,000 | 21,300,000 | 12,480,023 | -7,626,529 |
| Dec 2022 | 5,992,054 | -15,845,690 | -20,037,573 | 32,400,000 | 15,718,747 | 16,702,467 | -12,797,325 |
| Dec 2021 | — | — | — | — | — | — | — |
TTM Snapshot
Revenues TTM
$0
NetIncome TTM
$-3,201,890
OpCashFlow TTM
—
Assets (Latest)
$3,545,719
Forward EPS
$-1.09
Peers — same industry
| Ticker | Name | Market Cap | Last | Daily % |
|---|---|---|---|---|
| TRFA | TRAFALGAR INTERNATIONAL, INC. | $149.4K | $0.75 | — |
| CNBX | CNBX Pharmaceuticals Inc. | $160.6K | $0.00 | — |
| RGBP | Regen BioPharma Inc | $167.5K | $0.00 | — |
| BNIGF | Beroni Group Ltd | $180.0K | $0.01 | — |
| SPRC | SciSparc Ltd. | $191.5K | $0.33 | — |
Recent Insider Activity
No insider activity indexed for this ticker.